Page last updated: 2024-11-02

picotamide and Embolism, Pulmonary

picotamide has been researched along with Embolism, Pulmonary in 1 studies

picotamide: has anticoagulant & fibrinolytic properties; structure

Research Excerpts

ExcerptRelevanceReference
"Picotamide did not inhibit the formation of TxB2 in serum at any of the doses tested (100 to 750 mg/kg i."5.28Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. ( Alberti, P; Corona, C; Gresele, P; Nenci, GG, 1990)
"Picotamide did not inhibit the formation of TxB2 in serum at any of the doses tested (100 to 750 mg/kg i."1.28Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. ( Alberti, P; Corona, C; Gresele, P; Nenci, GG, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gresele, P1
Corona, C1
Alberti, P1
Nenci, GG1

Other Studies

1 other study available for picotamide and Embolism, Pulmonary

ArticleYear
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
    Thrombosis and haemostasis, 1990, Aug-13, Volume: 64, Issue:1

    Topics: Animals; Aspirin; Disease Models, Animal; Epoprostenol; Male; Mice; Phthalic Acids; Platelet Aggrega

1990